Author

Diana Marcela Tabima

University of Wisconsin–MadisonORCID 0000-0001-6354-3617Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Assay:metabolomics· 1

Frequent Co-Authors

Krishanu SahaiD· 2 shared Amr A. AbdeeniD· 1 shared Bikash Ranjan PattnaikiD· 1 shared Brittany Russell· 1 shared Christian M. CapitiniiD· 1 shared Christine A. Caneba· 1 shared Daniel Maldonado· 1 shared David M. GammiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Krishanu SahaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

GenomicsNature CommunicationsPeer-reviewedAug 13, 2026

Genome-Wide CRISPR Screening Identifies Cellular Factors Controlling Nonviral Genome Editing Efficiency

Shivani Saxena, Meha Kabra, Amr A. Abdeen…·Krishanu Saha

The paper uses CRISPR screening to identify genes that enhance nonviral genome editing efficiency in human cells, finding six genes that increase editing efficiency by up to five-fold.

DOI 10.1038/s41467-026-76350-5

humanCRISPR screen

𝕏 PostBluesky

BioengineeringbioRxivPreprintJan 27, 2025

Hypoxia modulates human pulmonary arterial adventitial fibroblast phenotype through HIF-1α activation

Jennifer L. Philip, Christine A. Caneba, Laura R. Caggiano…·Naomi C. Chesler

This study investigates how hypoxia affects human pulmonary arterial adventitial fibroblasts through HIF-1α activation, showing increased collagen and decreased MMP2 activity.

2 citations

humanproteomics

𝕏 PostBluesky

BioengineeringMolecular TherapyPeer-reviewedJan 14, 2025

Virus-free CRISPR knock-in of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells

Keerthana Shankar, Isabelle Zingler-Hoslet, Diana Marcela Tabima…·Krishanu Saha

This study uses CRISPR to disrupt an inhibitory receptor in NK cells and insert a GD2-targeting CAR, creating potent NK cells against GD2+ melanoma.

23 citationstop 2%

humangenetic perturbation / CRISPR

𝕏 PostBluesky